| Literature DB >> 27446018 |
Lu Han1, Dana Ziuzina1, Caitlin Heslin1, Daniela Boehm1, Apurva Patange1, David M Sango2, Vasilis P Valdramidis2, Patrick J Cullen3, Paula Bourke1.
Abstract
Atmospheric cold plasma (ACP) is a non-thermal technology, effective against a wide range of pathogenic microorganisms. Inactivation efficacy results from plasma generated reactive species. These may interact with any organic components in a test matrix including the target microorganism, thus food components may exert a protective effect against the antimicrobial mode of action. The effect of an in-package high voltage ACP process applied in conjunction with common meat processing MAP gas compositions as well as bacteria type and meat model media composition have been investigated to determine the applicability of this technology for decontamination of safety challenges associated with meat products. E. coli, L. monocytogenes, and S. aureus in PBS were undetectable after 60 s of treatment at 80 kVRMS in air, while ACP treatment of the contaminated meat model required post-treatment refrigeration to retain antimicrobial effect. The nutritive components in the meat model exerted a protective effect during treatment, where 300 s ACP exposure yielded a maximum reduction of 1.5 log using a high oxygen atmosphere, whilst using air and high nitrogen atmospheres yielded lower antimicrobial efficacy. Furthermore, an ROS assay was performed to understand the protective effects observed using the meat model. This revealed that nutritive components inhibited penetration of ROS into bacterial cells. This knowledge can assist the optimization of meat decontamination using ACP technology where interactions with all components of the food matrix require evaluation.Entities:
Keywords: Gram negative and positive bacteria; ROS; beef extract; biofilm; high voltage plasma
Year: 2016 PMID: 27446018 PMCID: PMC4916165 DOI: 10.3389/fmicb.2016.00977
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Figure 1Biofilm inactivation efficacy with applied voltage and treatment time (24 h storage at room temperature). (A) E. coli NCTC 12900; (B) L. monocytogenes NCTC 11994; (C) S. aureus NCTC 1803. Dotted line: detection limit; ▲: 60 kVRMS; ●: 70 kVRMS; ■: 80 kVRMS.
Figure 2Voltage associated intracellular ROS density assay by DCFH DA. Samples in PBS were treated for 60 s at 60 kVRMS, 70 kVRMS, and 80 kVRMS and analyzed without post-treatment storage.
.
| 3% BE | C1* | 7.11ab | 0.06 | 6.96a | 0.19 |
| C2* | 6.95bc | 0.11 | 9.18b | 0.16 | |
| 60 | 7.35b | 0.25 | 9.11b | 0.13 | |
| 120 | 6.73c | 0.13 | 9.15b | 0.13 | |
| 300 | 6.06d | 0.15 | 8.41c | 0.55 | |
| 12% BE | C1* | 7.13ab | 0.16 | 7.02a | 0.29 |
| C2* | 7.18ab | 0.21 | 9.39d | 0.07 | |
| 60 | 7.32b | 0.04 | 9.47d | 0.17 | |
| 120 | 7.12c | 0.68 | 9.33bd | 0.26 | |
| 300 | 5.79d | 0.92 | 9.35d | 0.36 | |
| PBS | C1* | 7.18ab | 0.09 | 6.94a | 0.19 |
| C2* | 6.94bc | 0.09 | 6.90a | 0.00 | |
| 60 | ND*e | – | ND*e | – | |
| 120 | ND*e | – | ND*e | – | |
| 300 | ND*e | – | ND*e | – | |
SD*, standard deviation; ND*, non-detectable; C1*, Control without storage; C2*, Control with storage. Different letters indicate a significant difference at the 0.05 level between media and treatment times.
.
| 3% BE | C1* | 7.29a | 0.04 | 6.03a | 0.46 |
| C2* | 6.63b | 0.26 | 8.87b | 0.01 | |
| 60 | 5.71c | 0.34 | 8.08bc | 0.17 | |
| 120 | 5.79c | 0.17 | 7.98c | 0.31 | |
| 300 | 5.02d | 0.33 | 7.03d | 0.58 | |
| 12% BE | C1* | 7.17e | 0.06 | 6.30a | 0.14 |
| C2* | 6.52b | 0.09 | 9.01e | 0.14 | |
| 60 | 6.33f | 0.33 | 8.83ef | 0.06 | |
| 120 | 6.35f | 0.22 | 8.76f | 0.07 | |
| 300 | 5.76g | 0.05 | 8.43g | 0.09 | |
| PBS | C1* | 7.40ah | 0.07 | 6.41a | 0.18 |
| C2* | 6.37b | 0.01 | 6.52a | 0.19 | |
| 60 | ND*i | – | ND*h | – | |
| 120 | ND*i | – | ND*h | – | |
| 300 | ND*i | – | ND*h | – | |
SD*, standard deviation; ND*, non-detectable; C1*, Control without storage; C2*, Control with storage. Different letters indicate a significant difference at the 0.05 level between media and treatment times.
Figure 3Media associated intracellular ROS density assay by DCFH DA. Samples in PBS, 3% BE and 12% BE were treated for 60 s, 120 s, and 300 s at 80 kVRMS and analyzed without post-treatment storage.
.
| 7.89 | 7.05 | |
| 8.39 | 8.62 | |
| 8.13 | 7.04 |
Kinetic parameters of the bacteria after different ACP treatment times at 80 kV.
| C | 1.26 | 0.55 | |
| 60 | 1.09 | 0.23 | |
| 120 | 0.59 | 0.20 | |
| 300 | 0.21 | 0.04 | |
| C | 0.35 | 0.07 | |
| 60 | 0.17 | 0.09 | |
| 120 | 0.28 | 0.30 | |
| 300 | 0.17 | 0.01 | |
| C | 0.86 | 0.29 | |
| 60 | 0.46 | 0.16 | |
| 120 | 0.46 | 0.11 | |
| 300 | 0.31 | 0.34 |
SD*, standard deviation.
Planktonic inactivation efficacy at 80 kV.
| 1 | C1* | 7.16a | 0.07 | 7.51a | 0.11 | 6.88a | 0.04 |
| C2* | 6.57b | 0.24 | 6.93b | 0.40 | 6.52b | 0.10 | |
| 15 | 6.87c | 0.09 | 6.48c | 0.09 | 6.21c | 0.11 | |
| 30 | 5.87d | 0.03 | 5.83d | 0.06 | 5.74d | 0.19 | |
| 60 | 5.74d | 0.05 | 5.21e | 0.10 | 5.39e | 0.10 | |
| 2 | C1* | 7.16a | 0.07 | 7.51a | 0.11 | 6.88a | 0.04 |
| C2* | 6.99ab | 0.07 | 6.93b | 0.40 | 6.78a | 0.08 | |
| 15 | 6.50b | 0.23 | 6.55bc | 0.13 | 5.47c | 0.40 | |
| 30 | 2.98e | 0.48 | 0.92f | 0.09 | 2.51f | 0.45 | |
| 60 | 0.00f | 0.00 | 0.00g | 0.00 | 0.00g | 0.00 | |
| 3 | C1* | 7.16a | 0.07 | 7.51a | 0.11 | 6.88a | 0.04 |
| C2* | 6.81ab | 0.10 | 6.05h | 0.17 | 6.30a | 0.08 | |
| 15 | 6.57b | 0.08 | 5.79d | 0.02 | 5.11c | 1.08 | |
| 30 | ND*f | – | ND*g | – | 1.71h | 0.36 | |
| 60 | ND*f | – | ND*g | – | ND*g | – | |
SD*, standard deviation; ND*, non-detectable; C1*, Control without storage; C2*, Control with storage. Different letters indicate a significant difference at the 0.05 level between gas mix and treatment times. Gases: 1 30% CO2 + 70% N2; 2 Air; 3 30% CO2+70% O2.
Planktonic inactivation efficacy at 80 kV.
| 1 | C1* | 6.78a | 0.03 | 7.17a | 0.09 | 6.63a | 0.07 |
| C2* | 7.18ce | 0.08 | 7.56c | 0.08 | 7.14b | 0.16 | |
| 60 | 7.64b | 0.13 | 7.28ab | 0.12 | 6.22c | 0.07 | |
| 120 | 7.49bc | 0.24 | 7.46bc | 0.06 | 6.27c | 0.07 | |
| 300 | 7.01ae | 0.25 | 7.34ac | 0.20 | 6.15c | 0.12 | |
| 2 | C1* | 6.98de | 0.05 | 7.02ef | 0.06 | 6.93a | 0.29 |
| C2* | 7.15ce | 0.06 | 7.56c | 0.08 | 7.23b | 0.05 | |
| 60 | 6.87df | 0.06 | 6.98e | 0.04 | 6.73d | 0.12 | |
| 120 | 6.74f | 0.10 | 7.18f | 0.05 | 6.73d | 0.06 | |
| 300 | 6.55g | 0.12 | 6.78d | 0.14 | 5.79c | 0.29 | |
| 3 | C1* | 6.98de | 0.01 | 6.99e | 0.03 | 6.81a | 0.06 |
| C2* | 7.23ce | 0.05 | 7.56c | 0.08 | 7.17b | 0.19 | |
| 60 | 6.47h | 0.14 | 6.55h | 0.22 | 5.85c | 0.35 | |
| 120 | 5.93i | 0.11 | 5.97g | 0.03 | 5.54e | 0.13 | |
| 300 | 5.49j | 0.17 | 4.77i | 0.05 | 4.63f | 0.11 | |
SD*, standard deviation; C1*, Control without storage; C2*, Control with storage. Different letters indicate a significant difference at the 0.05 level between gas mix and treatment times. Gases: 1 30% CO2+70% N2; 2 Air; 3 30% CO2+70% O2.
Figure 4Applied gases associated intracellular ROS density assay by DCFH DA. Samples in PBS treated for 60 s at 80 kVRMS in applied gases: 30% CO2+70% N2; Air and 30% CO2+70% O2 and analyzed without post-treatment storage.
In-package ozone concentration with different MAP gases after different ACP treatment at 80 kV.
| 15 | ND* | ND* | 533 | 231 | 1280 | 179 |
| 30 | ND* | ND* | 1067 | 493 | 5400 | 849 |
| 60 | ND* | ND* | 2450 | 496 | 12050 | 2375 |
| 120 | ND* | ND* | 2814 | 1619 | 12240 | 1951 |
| 300 | ND* | ND* | 2950 | 191 | 16480 | 2305 |
SD*, standard deviation; ND*, non-detectable.
Figure 5Proposed mechanism of action of ACP generated ROS in bacteria suspensions of PBS and BE.
.
| 3% BE | C1* | 7.23a | 0.06 | 7.23a | 0.06 |
| C2* | 7.35a | 0.01 | 9.10b | 0.03 | |
| 60 | 7.23a | 0.14 | 8.90b | 0.09 | |
| 120 | 6.70b | 0.23 | 8.60b | 0.09 | |
| 300 | 5.07c | 0.35 | 7.20a | 0.84 | |
| 12% BE | C1* | 7.26a | 0.10 | 7.26a | 0.10 |
| C2* | 7.43d | 0.02 | 9.63c | 0.05 | |
| 60 | 7.32d | 0.19 | 9.00d | 0.07 | |
| 120 | 7.54d | 0.19 | 9.16cd | 0.08 | |
| 300 | 6.18e | 0.19 | 7.93e | 0.49 | |
| PBS | C1* | 7.29a | 0.04 | 7.29a | 0.04 |
| C2* | 7.08g | 0.01 | 6.84f | 0.03 | |
| 60 | ND*h | – | ND*g | – | |
| 120 | ND*h | – | ND*g | – | |
| 300 | ND*h | – | ND*g | – | |
SD*, standard deviation; ND*, non-detectable; C1*, Control without storage; C2*, Control with storage. Different letters indicate a significant difference at the 0.05 level between media and treatment times.